Envigo is launching the “R2G2” mouse, a Rag2/IL2RG double knockout model to help address common challenges researchers experience with current models used in oncology, immuno-oncology and infectious disease research.     One key benefits of the R2G2 that makes it ideal for oncology research is the model’s reduced radiosensitivity, meaning it has the ability to tolerate the effects of a wider range of radiation dosages. This helps researchers more closely simulate the treatment environments of ...